Lupus Nephritis: Experience of Treatment with Rituximab (Clinical Observation)

Authors

  • D.D. Ivanov
  • N.O. Tikhonenko
  • K.V. Tomin

DOI:

https://doi.org/10.22141/2307-1257.0.2.2012.176616

Abstract

No abstract

Downloads

Download data is not yet available.

References

Bomback A.S., Appel G.B. Updatesonthe Treatmentof Lupus Nephritis // JASN. — 2010. — Vol. 21, № 12. — P. 2028-2035.

Efficacy and Safety of Rituximab in Patients With Active Proliferative Lupus Nephritis: The LUpus Nephritis Assessment With Rituximab (LUNAR) Study / Rovin et al. // Arthritis & Rheumatism. — 2012.

Ezeonyeji A.N., Isenberg D.A. Early treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimen // Rheumatology. — 2012. — Vol. 51, Issue 3. — P. 476-481.

Jónsdóttir T.,Sundelin B., Henriksson E.W., Vollenhoven R.F., Gunnarsson I.Rituximab-treated membranous lupus nephritis: clinical outcome and effects on electron dense deposits // Ann. Rheum. Dis doi:10.1136/ard.2010.129288

Kamanamool N., McEvoy M., Attia J., Ingsathit A., Ngamjanyaporn P., Thakkinstian A. Efficacy and adverse events of mycophenolatemofetil versus cyclophosphamide for induction therapy of lupus nephritis: systematic review and meta-analysis // Medicine. — 2010. — Vol. 89. — № 4. — P. 227-235, doi:10.1097/MD.0b013e3181e93d00

http://medi.ru/doc/22202.htm

http://www.slideshare.net/edwinchowyw/lupus-nephritis

Downloads

Published

2022-02-15

How to Cite

Ivanov, D., Tikhonenko, N., & Tomin, K. (2022). Lupus Nephritis: Experience of Treatment with Rituximab (Clinical Observation). KIDNEYS, (2), 68–70. https://doi.org/10.22141/2307-1257.0.2.2012.176616

Issue

No. 2 (2012)

Section

Clinical Observation

License

Copyright (c) 2012 D.D. Ivanov, N.O. Tikhonenko, K.V. Tomin

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.